Composition
- Active ingredients
- PIPERACILLIN SODIUM EQ 3GM BASE/VIAL; TAZOBACTAM SODIUM EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- PIPERACILLIN SODIUM EQ 36GM BASE/VIAL; TAZOBACTAM SODIUM EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050684-004 · Discontinued
- PIPERACILLIN SODIUM EQ 3GM BASE/VIAL; TAZOBACTAM SODIUM EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- PIPERACILLIN SODIUM EQ 4GM BASE/VIAL; TAZOBACTAM SODIUM EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050684-003 · Discontinued
- PIPERACILLIN SODIUM EQ 2GM BASE/VIAL; TAZOBACTAM SODIUM EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA050684-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050684.
At a glance
- Brand name
- Zosyn
- Active substance
- piperacillin sodium
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Wyeth Pharms
- Status
- Discontinued
- FDA approval
- 22 Oct 1993
- Application
- NDA050684-002